CANTANHEDE, Portugal, Oct. 16, 2023 Tilray Medical, a division of Tilray Brands, Inc. and a global leader in medical cannabis, empowering the therapeutic alliance between patients and.
On Monday, Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), announced its contribution to an independent clinical trial to research the efficacy of medical cannabis as a treatment for glioblastoma, which is a seve